Marisa joined the Imperial College Business School and the Health Care Management Group as an Assistant Professor in Economics in 2008.
In the past she has held academic appointments at the Centre for Health Economics and the Department of Economics and Related Studies both at the University of York.
Marisa holds a PhD in economics from York University, a MSc in Economics and Finance from Universitat Pompeu Fabra, a Master of Arts in Economics from Université Catholique de Louvain and a first degree in economics from Universidade Católica Portuguesa.
Marisa has developed expertise in public policy and pharmaceutical economics by having participated in research projects commissioned by the Department of Health focusing on topics such as competition and regulation in secondary and primary care, competition between public and private providers and the impact of public policy on Pharmaceutical firms' strategies.
She is particularly interested in regulation and competition in the health care sector and, more generally, in the public sector.
et al., 2009, Are Treatment Centres treating less complex patients?, Health Policy, Forthcoming
et al., 2017, Vertical and horizontal equity of funding for malaria control: a global multisource funding analysis for 2006-2010., Bmj Glob Health, Vol:2, ISSN:2059-7908
et al., 2017, Evaluating the importance of policy amenable factors in explaining influenza vaccination: a cross-sectional multinational study, Bmj Open, Vol:7, ISSN:2044-6055
Camejo RR, Miraldo M, Rutten F, 2017, Cost-Effectiveness and Dynamic Efficiency: Does the Solution Lie Within?, Value in Health, Vol:20, ISSN:1098-3015, Pages:240-243